Recognition and Initial Management of Acute Ischemic Stroke

Emergency Medicine Clinics of North America

Volumn 30, Issue 3, 2012, Pages 637-657

  Perry, Jillian M ^a   McCabe, Kerry K ^b  

^a BOSTON MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ischemic stroke; Recognition of stroke; Stroke; Stroke management; Thrombolytics in stroke

Indexed keywords

ALTEPLASE; GLUCOSE; TISSUE PLASMINOGEN ACTIVATOR;

ANTERIOR CEREBRAL ARTERY; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; BRAIN VEIN; CAUSE OF DEATH; CEREBRAL SINUS THROMBOSIS; CEREBROVASCULAR ACCIDENT; CLINICAL EXAMINATION; CLINICAL PROTOCOL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; EMERGENCY PHYSICIAN; EMERGENCY WARD; HUMAN; INTERNAL CAROTID ARTERY; INTRACRANIAL PRESSURE; LABORATORY TEST; MIDDLE CEREBRAL ARTERY; MORBIDITY; MORTALITY; NATIONAL HEALTH ORGANIZATION; PHYSICAL EXAMINATION; POSTERIOR INFERIOR CEREBELLAR ARTERY; PRIORITY JOURNAL; RECOGNITION; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; UNITED STATES; VEIN THROMBOSIS; VERTEBRAL ARTERY;

EID: 84866153097     PISSN: 07338627     EISSN: 07338627     Source Type: Journal    
DOI: 10.1016/j.emc.2012.06.001     Document Type: Review

References (71)

1. Roger V.L., Go A.S., Lloyd-Jones D.M., et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011, 123(4):e18-e209.
2. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995, 333(24):1581-1587.
3. Fonarow G.C., Saver J.L., Saver J.L., et al. Improving door-to-needle times in acute ischemic stroke: the design and rationale for the american heart association/american stroke association's target: stroke initiative. Stroke 2011, 42(10):2983-2989.
4. Adams and victor's principles of neurology 2009, The McGraw-Hill Companies, Inc. 9th edition. A.H. Ropper, M.A. Samuels (Eds.).
5. Maulaz A.B., Bezerra D.C., Bogousslavsky J. Posterior cerebral artery infarction from middle cerebral artery infarction. Arch Neurol 2005, 62(6):938-941.
6. Fisher C.M. Capsular infarcts: the underlying vascular lesions. Arch Neurol 1979, 36(2):65-73.
7. Caplan L.R. Intracranial branch atheromatous disease: a neglected, understudied, and underused concept. Neurology 1989, 39(9):1246-1250.
8. Edlow J.A., Newman-Toker D.E., Savitz S.I. Diagnosis and initial management of cerebellar infarction. Lancet Neurol 2008, 7(10):951-964.
9. Nadeau S., Jordan J., Mishra S. Clinical presentation as a guide to early prognosis in vertebrobasilar stroke. Stroke 1992, 23(2):165-170.
10. Sacco S.E., Whisnant J.P., Broderick J.P., et al. Epidemiological characteristics of lacunar infarcts in a population. Stroke 1991, 22(10):1236-1241.
11. Fisher C.M. Lacunar strokes and infarcts: a review. Neurology 1982, 32(8):871-876.
12. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med 2005, 352(17):1791-1798.
13. Ferro J.M., Canhao P., Stam J., et al. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004, 35(3):664-670.
14. Saposnik G., Barinagarrementeria F., Brown R.J., et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011, 42(4):1158-1192.
15. Ferro J.M., Canhao P., Stam J., et al. Delay in the diagnosis of cerebral vein and dural sinus thrombosis: influence on outcome. Stroke 2009, 40(9):3133-3138.
16. Hacke W., Kaste M., Bluhmki E., et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008, 359(13):1317-1329.
17. Jauch E.C., Cucchiara B., Adeoye O., et al. Part 11: adult stroke: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010, 122(18 Suppl 3):S818-S828.
18. Schwamm L.H., Pancioli A., Acker J.E., et al. Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the development of stroke systems. Stroke 2005, 36(3):690-703.
19. Kothari R., Barsan W., Brott T., et al. Frequency and accuracy of prehospital diagnosis of acute stroke. Stroke 1995, 26(6):937-941.
20. Kothari R.U., Pancioli A., Liu T., et al. Cincinnati Prehospital Stroke Scale: reproducibility and validity. Ann Emerg Med 1999, 33(4):373-378.
21. Frendl D.M., Strauss D.G., Underhill B.K., et al. Lack of impact of paramedic training and use of the Cincinnati Prehospital Stroke Scale on stroke patient identification and on-scene time. Stroke 2009, 40(3):754-756.
22. Ramanujam P., Guluma K.Z., Castillo E.M., et al. Accuracy of stroke recognition by emergency medical dispatchers and paramedics-San Diego experience. Prehosp Emerg Care 2008, 12(3):307-313.
23. Kidwell C.S., Starkman S., Eckstein M., et al. Identifying stroke in the field: prospective validation of the Los Angeles Prehospital Stroke Screen (LAPSS). Stroke 2000, 31(1):71-76.
24. Adams H.P., del Zoppo G., Alberts M.J., et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007, 38(5):1655-1711.
25. Carter A.M., Catto A.J., Mansfield M.W., et al. Predictive variables for mortality after acute ischemic stroke. Stroke 2007, 38(6):1873-1880.
26. Singhal A.B. Oxygen therapy in stroke: past, present, and future. Int J Stroke 2006, 1(4):191-200.
27. Okumura K., Ohya Y., Maehara A., et al. Effects of blood pressure levels on case fatality after acute stroke. J Hypertens 2005, 23(6):1217-1223.
28. Vemmos K.N., Tsivgoulis G., Spengos K., et al. U-shaped relationship between mortality and admission blood pressure in patients with acute stroke. J Intern Med 2004, 255(2):257-265.
29. Leonardi-Bee J., Bath P., Phillips S.J., et al. Blood pressure and clinical outcomes in the international stroke trial. Stroke 2002, 33(5):1315-1320.
30. Castillo J., Leira R., Garcia M.M., et al. Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome. Stroke 2004, 35(2):520-526.
31. Sandset E.C., Bath P.M., Boysen G., et al. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet 2011, 377(9767):741-750.
32. Mokin M., Kass-Hout T., Kass-Hout O., et al. Blood pressure management and evolution of thrombolysis-associated intracerebral hemorrhage in acute ischemic stroke. J Stroke Cerebrovasc Dis 2011 Jun 22, [Epub ahead of print].
33. Kallmunzer B., Kollmar R. Temperature management in stroke-an unsolved, but important topic. Cerebrovasc Dis 2011, 31(6):532-543.
34. Groysman L.I., Emanuel B.A., Kim-Tenser M.A., et al. Therapeutic hypothermia in acute ischemic stroke. Neurosurg Focus 2011, 30(6):E17.
35. Ntaios G., Egli M., Faouzi M., et al. J-shaped association between serum glucose and functional outcome in acute ischemic stroke. Stroke 2010, 41(10):2366-2370.
36. Capes S.E., Hunt D., Malmberg K., et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients. Stroke 2001, 32(10):2426-2432.
37. Ahmed N., Davalos A., Eriksson N., et al. Association of admission blood glucose and outcome in patients treated with intravenous thrombolysis: results from the Safe Implementation of Treatments in Stroke International Stroke Thrombolysis Register (SITS-ISTR). Arch Neurol 2010, 67(9):1123-1130.
38. Bruno A., Levine S.R., Frankel M.R., et al. Admission glucose level and clinical outcomes in the NINDS rt-PA stroke trial. Neurology 2002, 59(5):669-674.
39. Goldstein L.B., Simel D.L. Is this patient having a stroke?. JAMA 2005, 293(19):2391-2402.
40. Runchey S., McGee S. Does this patient have a hemorrhagic stroke? clinical findings distinguishing hemorrhagic stroke from ischemic stroke. JAMA 2010, 303(22):2280-2286.
41. Goldstein L.B., Samsa G.P. Reliability of the National Institutes of Health Stroke Scale. Extension to non-neurologists in the context of a clinical trial. Stroke 1997, 28(2):307-310.
42. Martin-Schild S., Albright K.C., Tanksley J., et al. Zero on the NIHSS does not equal the absence of stroke. Ann Emerg Med 2011, 57(1):42-45.
43. Woo D., Broderick J.P., Kothari R.U., et al. Does the National Institutes of Health Stroke Scale favor left hemisphere strokes? NINDS t-PA Stroke Study Group. Stroke 1999, 30(11):2355-2359.
44. Rost N.S., Masrur S., Pervez M.A., et al. Unsuspected coagulopathy rarely prevents IV thrombolysis in acute ischemic stroke. Neurology 2009, 73(23):1957-1962.
45. Cucchiara B.L., Jackson B., Weiner M., et al. Usefulness of checking platelet count before thrombolysis in acute ischemic stroke. Stroke 2007, 38(5):1639-1640.
46. Walter S., Kostopoulos P., Haass A., et al. Point-of-care laboratory halves door-to-therapy-decision time in acute stroke. Ann Neurol 2011, 69(3):581-586.
47. Latchaw R.E. The roles of diffusion and perfusion MR imaging in acute stroke management. AJNR Am J Neuroradiol 1999, 20(6):957-959.
48. Tomandl B.F., Klotz E., Handschu R., et al. Comprehensive imaging of ischemic stroke with multisection CT. Radiographics 2003, 23(3):565-592.
49. Kang D.W., Chalela J.A., Dunn W., et al. MRI screening before standard tissue plasminogen activator therapy is feasible and safe. Stroke 2005, 36(9):1939-1943.
50. Kidwell C.S., Chalela J.A., Saver J.L., et al. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA 2004, 292(15):1823-1830.
51. Fiebach J.B., Schellinger P.D., Jansen O., et al. CT and diffusion-weighted MR imaging in randomized order: diffusion-weighted imaging results in higher accuracy and lower interrater variability in the diagnosis of hyperacute ischemic stroke. Stroke 2002, 33(9):2206-2210.
52. Mullins M.E., Schaefer P.W., Sorensen A.G., et al. CT and conventional and diffusion-weighted MR imaging in acute stroke: study in 691 patients at presentation to the emergency department. Radiology 2002, 224(2):353-360.
53. Sorensen A.G., Copen W.A., Ostergaard L., et al. Hyperacute stroke: simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean tissue transit time. Radiology 1999, 210(2):519-527.
54. Keir S.L., Wardlaw J.M. Systematic review of diffusion and perfusion imaging in acute ischemic stroke. Stroke 2000, 31(11):2723-2731.
55. Murray V., Norrving B., Sandercock P.A., et al. The molecular basis of thrombolysis and its clinical application in stroke. J Intern Med 2010, 267(2):191-208.
56. Frendl A., Csiba L. Pharmacological and non-pharmacological recanalization strategies in acute ischemic stroke. Front Neurol 2011, 2:32.
57. Hommel M., Boissel J.P., Cornu C., et al. Termination of trial of streptokinase in severe acute ischaemic stroke. Lancet 1995, 345(8941):57.
58. Donnan G.A., Davis S.M., Chambers B.R., et al. Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group. JAMA 1996, 276(12):961-966.
59. Hacke W., Kaste M., Fieschi C., et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995, 274(13):1017-1025.
60. Hacke W., Kaste M., Fieschi C., et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998, 352(9136):1245-1251.
61. Clark W.M., Albers G.W., Madden K.P., et al. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g): results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators. Stroke 2000, 31(4):811-816.
62. Clark W.M., Wissman S., Albers G.W., et al. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 1999, 282(21):2019-2026.
63. Hacke W., Donnan G., Fieschi C., et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004, 363(9411):768-774.
64. Lansberg M.G., Bluhmki E., Thijs V.N. Efficacy and safety of tissue plasminogen activator 3 to 4.5 hours after acute ischemic stroke: a metaanalysis. Stroke 2009, 40(7):2438-2441.
65. Lees K.R., Bluhmki E., von Kummer R., et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010, 375(9727):1695-1703.
66. del Zoppo G.J., Saver J.L., Jauch E.C., et al. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke 2009, 40(8):2945-2948.
67. Furlan A., Higashida R., Wechsler L., et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999, 282(21):2003-2011.
68. Meyers P.M., Schumacher H.C., Connolly E.S., et al. Current status of endovascular stroke treatment. Circulation 2011, 123(22):2591-2601.
69. Broderick J.P. Endovascular therapy for acute ischemic stroke. Stroke 2009, 40(3 Suppl 1):S103-S106.
70. Falluji N., Abou-Chebl A., Rodriguez Castro C.E., et al. Reperfusion strategies for acute ischemic stroke. Angiology 2012, 63(4):289-296. [Epub 2011 Jul 6].
71. Rha J.H., Saver J.L. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 2007, 38(3):967-973.